Individually dosed omalizumab facilitates peanut oral immunotherapy in peanut allergic adolescents.
Josef BrandströmMirja VetanderAnn-Charlotte SundqvistGunnar LiljaS G O JohanssonErik MelénEva Sverremark-EkströmAnna NoppCaroline NilssonPublished in: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2019)
ClinicalTrials.gov; NCT02402231. EudraCT; 2012-005625-78.
Keyphrases